Anonymous12 days ago
A Bundibugyo ebolavirus outbreak declared a public health emergency of international concern has now killed over 340 people across the DRC and Uganda, yet no licensed vaccine or treatment exists for this strain. CEPI has committed $62 million to fast-track three experimental vaccines from Moderna, Oxford/Serum Institute of India, and IAVI — but the fastest candidate is still months from clinical trials, raising hard questions about why the world failed to prepare despite seven years of warnings since Ervebo's approval.